Ikarian Capital, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$9,802,000
+710.6%
845
-91.8%
1.18%
+510.9%
Q2 2023$1,209,220
+46.6%
10,3000.0%0.19%
+3.2%
Q1 2023$824,618
-93.7%
10,300
-93.8%
0.19%
-94.1%
Q4 2022$13,142,598
+98.1%
165,900
+74.3%
3.17%
+139.9%
Q3 2022$6,635,000
-77.9%
95,200
-83.4%
1.32%
-37.4%
Q3 2021$30,012,000574,8002.11%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders